Language:

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

Biometals, 2016-06, Vol.29 (3), p.365-376 [Peer Reviewed Journal]

The Author(s) 2016 ;Springer Science+Business Media New York 2016 ;ISSN: 0966-0844 ;EISSN: 1572-8773 ;DOI: 10.1007/s10534-016-9931-7 ;PMID: 27053146

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
Author: Rogosnitzky, Moshe ; Branch, Stacy
Subjects: Biochemistry ; Biomedical and Life Sciences ; Bones ; Cell Biology ; Contrast agents ; Contrast Media - adverse effects ; Contrast Media - metabolism ; Contrast Media - pharmacokinetics ; Dosing ; Fibrosis ; Gadolinium ; Gadolinium - adverse effects ; Gadolinium - metabolism ; Gadolinium - pharmacokinetics ; Heavy metals ; Humans ; Impairment ; Life Sciences ; Medicine/Public Health ; Microbiology ; Molecular biology ; NMR ; Nuclear magnetic resonance ; Patients ; Pharmacology/Toxicology ; Plant Physiology ; Toxicity
Is Part Of: Biometals, 2016-06, Vol.29 (3), p.365-376
Description: Gadolinium chelates are widely used as contrast media for magnetic resonance imaging. The approved gadolinium-based contrast agents (GBCAs) have historically been considered safe and well tolerated when used at recommended dosing levels. However, for nearly a decade, an association between GBCA administration and the development of nephrogenic systemic fibrosis (NSF) has been recognized in patients with severe renal impairment. This has led to modifications in clinical practices aimed at reducing the potential and incidence of NSF development. Newer reports have emerged regarding the accumulation of gadolinium in various tissues of patients who do not have renal impairment, including bone, brain, and kidneys. Despite the observations of gadolinium accumulation in tissues regardless of renal function, very limited clinical data regarding the potential for and mechanisms of toxicity is available. This significant gap in knowledge warrants retrospective cohort study efforts, as well as prospective studies that involve gadolinium ion (Gd 3+ ) testing in patients exposed to GBCA. This review examines the potential biochemical and molecular basis of gadolinium toxicity, possible clinical significance of gadolinium tissue retention and accumulation, and methods that can limit gadolinium body burden.
Publisher: Dordrecht: Springer Netherlands
Language: English;Dutch
Identifier: ISSN: 0966-0844
EISSN: 1572-8773
DOI: 10.1007/s10534-016-9931-7
PMID: 27053146
Source: Springer Nature OA
AUTh Library subscriptions: ProQuest Central
MEDLINE

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

The Author(s) 2016 ;Springer Science+Business Media New York 2016 ;ISSN: 0966-0844 ;EISSN: 1572-8773 ;DOI: 10.1007/s10534-016-9931-7 ;PMID: 27053146

Searching Remote Databases, Please Wait